IP Library Granted Patent US 6,884,616
Granted Patent B1
US 6,884,616 · App. 09/559,344 · Granted Apr 26, 2005

DNA-construct for the tissue-specific expression of a blood coagulation factor

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,884,616
App. No.
09/559,344
Granted
Apr 26, 2005
Kind
B1
Abstract

A DNA-construct has been disclosed which is suitable for a tissue-specific expression of a blood coagulation factor like Factor IX, which comprises a DNA coding for an amino acid sequence of a blood coagulation factor and a DNA coding for a promoter which is specific for the expression in hematopoietic cells.

Claims (13)

1. A DNA-construct for the tissue-specific expression of a blood coagulation factor comprising a DNA sequence coding for an amino acid sequence of a blood coagulation factor and a DNA sequence functioning as a promoter which is specific for expression in megakaryocytes, wherein the DNA sequence functioning as a promoter is the DNA sequence for the human platelet glycoprotein IIb (GPIIb) promoter.

2. The DNA-construct as claimed in claim 1 , wherein the blood coagulation factor is Factor IX.

3. The DNA-construct as claimed in claim 1 , wherein a first truncated intron (Intron 1) of the human FIX gene is inserted into the DNA sequence coding for an amino acid sequence of a blood coagulation factor.

4. A process for the production of a blood coagulation factor in a megakaryocyte cell line comprising:

transfecting megakaryocyte cells with a DNA-construct coding for a blood coagulation factor comprising:

a DNA sequence coding for the amino acid sequence of a blood coagulation factor, and

a DNA sequence functioning as a promoter which is specific for expression in megakaryocytes; and

expressing the DNA-construct.

5. The process as claimed in claim 4 , wherein the production of the blood coagulation factor is stimulated by an inducer.

6. The process as claimed in claim 5 , wherein the inducer is phorbol-12-myristate-13-acetate (PMA).

7. The process according to claim 4 wherein the DNA sequence functioning as a promoter is the DNA sequence for the human platelet glycoprotein IIb (GPIIb) promoter.

8. The process according to claim 4 , wherein the blood coagulation factor is Factor IX.

9. The process according to claim 4 , wherein a first truncated intron (Intron 1) of the human FIX gene is inserted into the DNA sequence coding for an amino acid sequence of a blood coagulation factor.

Assignments (2)
CHANGE OF NAME Recorded Sep 10, 2007
From: ZLB BEHRING GMBH
To: CSL BEHRING GMBH
Reel/Frame 019840/0193 →
CHANGE OF NAME Recorded Nov 12, 2004
From: AVENTIS BEHRING GMBH
To: ZLB BEHRING GMBH
Reel/Frame 015372/0411 →